From protecting individual babies to reducing hospital admissions, studies from around the world are revealing the benefits of RSV vaccination.

An agreement announced today will cut the price of the RTS,S/AS01 malaria vaccine by approximately 40 per cent. The deal, executed by UNICEF and financially backed by Gavi, the Vaccine Alliance, is ...

If you would like to republish this article, please follow these steps: use the HTML below; do not edit the text; include the author’s byline; credit VaccinesWork as the original source; and include ...

If you would like to republish this article, please follow these steps: use the HTML below; do not edit the text; include the author’s byline; credit VaccinesWork as the original source; and include ...

If you would like to republish this article, please follow these steps: use the HTML below; do not edit the text; include the author’s byline; credit VaccinesWork as the original source; and include ...

If you would like to republish this article, please follow these steps: use the HTML below; do not edit the text; include the author’s byline; credit VaccinesWork as the original source; and include ...

If you would like to republish this article, please follow these steps: use the HTML below; do not edit the text; include the author’s byline; credit VaccinesWork as the original source; and include ...

Gavi-supported immunisation generated more than US$ 30 billion in economic benefits in 2025, through lower healthcare costs and healthier, more productive populations Dr Sania Nishtar, Gavi CEO: "When ...

President Bio of Sierra Leone and Gavi CEO Dr Sania Nishtar discuss immunisation progress, sustainable health financing and global health reform. President Bio: “When we invest in immunisation, we are ...

Welcome to Gavi’s 2025 Annual Progress Report, the fifth and final report of Gavi’s 2021–2025 strategic period (Gavi 5.0/5.1). After a year of challenges, Gavi can look forward with optimism; when the ...